Related Experiment Video
Updated: Jun 19, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
In silico approach towards polyphenols as targeting glucosamine-6-phosphate synthase for Candida albicans
Sachin Dhawale1, Madhuri Pandit1, Kanchan Thete1
1Department of Pharmaceutical Chemistry, Shreeyash Institute of Pharmaceutical education and research, Aurangabad, Maharashtra, India.
Abstract:
Candida albicans is one of the most common species of fungus with life-threatening systemic infections and a high mortality rate. The outer cell wall layer of C. albicans is packed with mannoproteins and glycosylated polysaccharide moieties that play an essential role in the interaction with host cells and tissues. The glucosamine-6-phosphate synthase enzyme produces N-acetylglucosamine, which is a crucial chemical component of the cell wall of Candida albicans. Collectively, these components are essential to maintain the cell shape and for infection. So, its disruption can have serious effects on cell growth and morphology, resulting in cell death. Hence, it is considered a good antifungal target. In this study, we have performed an in silico approach to analyze the inhibitory potential of some polyphenols obtained from plants. Those can be considered important in targeting against the enzyme glucosamine-6-phosphate synthase (PDB-2VF5). The results of the study revealed that the binding affinity of complexes theaflavin and 3-o-malonylglucoside have significant docking scores and binding free energy followed by significant ADMET parameters that predict the drug-likeness property and toxicity of polyphenols as potential ligands. A molecular dynamic simulation was used to test the validity of the docking scores, and it showed that the complex remained stable during the period of the simulation, which ranged from 0 to 100 ns. Theaflavins and 3-o-malonylglucoside may be effective against Candida albicans using a computer-aided drug design methodology that will further enable researchers for future in vitro and in vivo studies, according to our in silico study.Communicated by Ramaswamy H. Sarma.
Insights
This study identified plant-derived polyphenols, theaflavin and 3-o-malonylglucoside, as potential inhibitors of glucosamine-6-phosphate synthase in Candida albicans. Computer simulations suggest these compounds could be effective antifungal agents, warranting further in vitro and in vivo research.
Area of Science:
- Biochemistry
- Mycology
- Computational Biology
Background:
- * Candida albicans causes life-threatening infections with high mortality.
- * Its cell wall, essential for survival and infection, is a key antifungal target.
- * Glucosamine-6-phosphate synthase is crucial for cell wall integrity.
Purpose of the Study:
- * To computationally screen plant-derived polyphenols for antifungal activity.
- * To identify inhibitors targeting Candida albicans glucosamine-6-phosphate synthase.
- * To evaluate the drug-likeness and toxicity of potential candidates.
Main Methods:
- * In silico analysis of polyphenol inhibitory potential.
- * Docking studies against glucosamine-6-phosphate synthase (PDB-2VF5).
- * Molecular dynamic simulations (0-100 ns) to assess complex stability.
- * ADMET parameter prediction for drug-likeness and toxicity.
Main Results:
- * Theaflavin and 3-o-malonylglucoside exhibited significant docking scores and binding free energy.
- * These compounds demonstrated favorable ADMET parameters, suggesting good drug-likeness.
- * Molecular dynamics simulations confirmed the stability of the polyphenol-enzyme complexes.
Conclusions:
- * Theaflavin and 3-o-malonylglucoside are promising candidates for antifungal drug development against Candida albicans.
- * Computer-aided drug design identified potential therapeutic agents.
- * Findings support further in vitro and in vivo investigations.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Antifungal Agents

